Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Equity Ratio (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Equity Ratio for 15 consecutive years, with 0.73 as the latest value for Q3 2025.

  • On a quarterly basis, Equity Ratio fell 8.48% to 0.73 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.73, a 8.48% decrease, with the full-year FY2024 number at 0.71, down 9.49% from a year prior.
  • Equity Ratio was 0.73 for Q3 2025 at Usana Health Sciences, up from 0.72 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.81 in Q2 2024 to a low of 0.68 in Q2 2022.
  • A 5-year average of 0.73 and a median of 0.73 in 2025 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: grew 10.48% in 2023, then decreased 10.87% in 2025.
  • Usana Health Sciences' Equity Ratio stood at 0.69 in 2021, then rose by 5.66% to 0.73 in 2022, then grew by 7.89% to 0.79 in 2023, then decreased by 9.49% to 0.71 in 2024, then grew by 2.19% to 0.73 in 2025.
  • Per Business Quant, the three most recent readings for USNA's Equity Ratio are 0.73 (Q3 2025), 0.72 (Q2 2025), and 0.71 (Q1 2025).